Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jack

Showing results (331-340 of 594) with videos related to

Pageof 60
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Loss of Fhit expression in head and neck squamous cell carcinoma and its potential clinical implicationShyh-Kuan Tai, Janet I Lee, K Kian Ang, et al.
The New England Journal of Medicine|April 9, 2004
The influence of resection and aneuploidy on mortality in oral leukoplakiaJon Sudbø, Scott M Lippman, J Jack Lee, et al.
Journal of the National Cancer Institute|September 18, 2015
Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-analysis of Clinical Trials Leading to FDA ApprovalDenis L Jardim, Denis L Fontes Jardim, Maria Schwaederle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2009
DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakiaPierre Saintigny, Adel K El-Naggar, Vali Papadimitrakopoulou, et al.
Cancer Causes & Control : CCC|May 17, 2003
Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States)Kim-Anh Do, Marcella M Johnson, Dorota A Doherty, et al.
Head & Neck|March 4, 2014
Phase II study of gefitinib in patients with advanced salivary gland cancersJohn A Jakob, Merrill S Kies, Bonnie S Glisson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 26, 2014
Membrane carbonic anhydrase IX expression and relapse risk in resected stage I-II non-small-cell lung cancerDavid J Stewart, Maria I Nunez, Carmen Behrens, et al.
British Journal of Cancer|November 1, 1996
Prospective evaluation of prognostic factors in operable breast cancerR A Hawkins, A L Tesdale, M E Killen, et al.
Cancer Research Communications|July 14, 2022
Real-World Studies Link Nonsteroidal Anti-inflammatory Drug Use to Improved Overall Lung Cancer SurvivalJason Roszik, J Jack Lee, Yi-Hung Wu, et al.
Cancer|March 13, 2010
Phase 2 study of carboplatin, docetaxel, and bevacizumab as frontline treatment for advanced nonsmall-cell lung cancerWilliam N William, Merrill S Kies, Frank V Fossella, et al.
Pageof 60

Showing results (331-340 of 594) with videos related to

Sort By:
Pageof 60
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Loss of Fhit expression in head and neck squamous cell carcinoma and its potential clinical implicationShyh-Kuan Tai, Janet I Lee, K Kian Ang, et al.
The New England Journal of Medicine|April 9, 2004
The influence of resection and aneuploidy on mortality in oral leukoplakiaJon Sudbø, Scott M Lippman, J Jack Lee, et al.
Journal of the National Cancer Institute|September 18, 2015
Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-analysis of Clinical Trials Leading to FDA ApprovalDenis L Jardim, Denis L Fontes Jardim, Maria Schwaederle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2009
DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakiaPierre Saintigny, Adel K El-Naggar, Vali Papadimitrakopoulou, et al.
Cancer Causes & Control : CCC|May 17, 2003
Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States)Kim-Anh Do, Marcella M Johnson, Dorota A Doherty, et al.
Head & Neck|March 4, 2014
Phase II study of gefitinib in patients with advanced salivary gland cancersJohn A Jakob, Merrill S Kies, Bonnie S Glisson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 26, 2014
Membrane carbonic anhydrase IX expression and relapse risk in resected stage I-II non-small-cell lung cancerDavid J Stewart, Maria I Nunez, Carmen Behrens, et al.
British Journal of Cancer|November 1, 1996
Prospective evaluation of prognostic factors in operable breast cancerR A Hawkins, A L Tesdale, M E Killen, et al.
Cancer Research Communications|July 14, 2022
Real-World Studies Link Nonsteroidal Anti-inflammatory Drug Use to Improved Overall Lung Cancer SurvivalJason Roszik, J Jack Lee, Yi-Hung Wu, et al.
Cancer|March 13, 2010
Phase 2 study of carboplatin, docetaxel, and bevacizumab as frontline treatment for advanced nonsmall-cell lung cancerWilliam N William, Merrill S Kies, Frank V Fossella, et al.
Pageof 60